<DOC>
	<DOCNO>NCT00757523</DOCNO>
	<brief_summary>The purpose study compare effectiveness two marketed product subject facial acne vulgaris</brief_summary>
	<brief_title>Evaluation Effectiveness , Safety , Tolerability Duac Akne Gel Epiduo Gel Treatment Facial Acne Vulgaris</brief_title>
	<detailed_description>Multiple physiopathological factor associate acne vulgaris . Drug combination frequently use address factor improve efficacy treatment acne . The current study proposes compare fixed-dose ( once-daily ) combination gel product contain benzoyl peroxide ( BPO ) clindamycin fixed-dose ( once-daily ) combination gel product contain BPO adapalene treatment facial acne vulgaris .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<criteria>Males females 12 45 year age , inclusive , good general health . Clinical diagnosis acne vulgaris Capable understanding willing provide sign dated write voluntary informed consent Female subject childbearing potential must negative pregnancy test baseline . Sexually active woman childbearing potential participating study must use medically acceptable form contraception Subjects treat estrogen , androgen , antiandrogenic agent 12 consecutive week prior first dose study product allow enroll long expect change dose , drug , discontinue use study . The ability willingness follow study procedure , attend schedule visit , successfully complete study . Female subject pregnant , try become pregnant , lactate . Any clinically relevant find baseline physical examination medical history severe systemic disease diseases facial skin acne vulgaris . Facial hair may obscure accurate assessment acne grade . History presence regional enteritis inflammatory bowel disease ( eg , ulcerative colitis , pseudomembranous colitis , chronic diarrhea , history antibioticassociated colitis ) similar symptom . Used topical antibiotic face systemic antibiotic within past 2 4 week , respectively . Used topical corticosteroid face systemic corticosteroid within past 4 week . Use inhale , intra articular intralesional ( facial acne lesion ) steroid acceptable . Used systemic retinoids within past 6 month . Using drug know photosensitizers ( eg , thiazide , tetracycline , fluoroquinolones , phenothiazine , sulfonamide ) possibility increase phototoxicity . Using neuromuscular block agent . Clindamycin neuromuscular blocking activity , may enhance action neuromuscular blocking agent . Used topical antiacne medication ( eg , BPO , retinoids , azelaic acid , resorcinol , salicylate , sulfacetamide sodium derivative , glycolic acid ) within past 2 week . Used investigational therapy within 4 week study day 1 . Using follow type facial product : astringent , toner , abradant , facial , peel contain glycolic acid , mask , wash soap contain BPO , sulfacetamide sodium salicylic acid , nonmild facial cleanser , moisturizers contain retinol , salicylic acid , α βhydroxy acid . Using medication report exacerbate acne ( eg , megadoses certain vitamin vitamin D , vitamin A , vitamins B2 , B6 , B12 ; haloperidol ; halogen iodide bromide ; lithium ; hydantoin ; phenobarbital ) may impact efficacy assessment . Have facial procedure ( chemical laser peel , microdermabrasion , artificial ultraviolet [ UV ] therapy ) perform esthetician , beautician , physician , nurse , practitioner , within past 4 week . Have know hypersensitivity previous allergic reaction active component , lincomycin , adapalene , clindamycin , BPO , excipients study medication . Employees clinical research organization involve study , Stiefel Laboratories , immediate family member ( partner , offspring , parent , sibling , sibling 's offspring ) employee . Have member household trial .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Acne</keyword>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Akne</keyword>
	<keyword>Akne Vulgaris</keyword>
</DOC>